Sale of 3,839 shares at $16.71 per share.
Reporting Person McNeill Jonathan · Officer Title President and COO · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062700 · filed 2026-09-18 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "CRESCENT BIOPHARMA, INC. (CBIO)." Disclosed 2026-09-18. https://desqlong.com/cards/0001628280-26-062700-2 (retrieved 2026-09-26).